Clinical Trials
4 trialsNCT06496373 2025-11-17
Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer
Ruijin Hospital
Phase EARLY_PHASE1 Recruiting
NCT06980155 2025-05-20
XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia
Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1 Recruiting
NCT05916248 2025-04-01
Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors
Ruijin Hospital
Phase EARLY_PHASE1 Recruiting
NCT06326736 2024-03-22
Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer
Jinling Hospital, China
Phase EARLY_PHASE1 Recruiting